Het Gezondheidsraadrapport 'Palliatieve chemotherapie'; risico van begripsverwarring

Translated title of the contribution: The Dutch Health Council Report on palliative chemotherapy; possible confusion of ideas

J. Verweij, P. H M De Mulder, H. M. Pinedo

Research output: Contribution to journalArticle

Abstract

The Dutch Health Council has issued a report advising the government on the care of cancer patients and on palliative chemotherapy in particular. The term palliative chemotherapy is ambiguous and may lead to confusion because it does not mean intention of cure and because the Council makes the assumption that palliative chemotherapy is used to enhance the quality of life, which is not in fact the case. In daily oncological clinical practice, prolonging life is the main objective. The report should have focused on better objectives for the systemic treatment of cancer. Four recommendations are contained within the report: (a) participation in clinical trials should be encouraged; the current implementation of good clinical practice guidelines and the Medical Research (Human Subjects) Act do not provide much support for this recommendation; (b) medication for palliative chemotherapy should be assessed for cost effectiveness; this is a political assessment and the responsibility for its implementation should not lie with the medical profession; (c) the quality of palliative chemotherapy should be ensured, therefore its application should be restricted to the trained medical oncologists; (d) in view of the complexity of the treatment nationwide guidelines are needed.

Original languageDutch
Pages (from-to)651-654
Number of pages4
JournalNederlands Tijdschrift voor Geneeskunde
Volume148
Issue number14
StatePublished - Apr 3 2004
Externally publishedYes

Fingerprint

Confusion
Drug Therapy
Health
Practice Guidelines
Cost-Benefit Analysis
Biomedical Research
Neoplasms
Patient Care
Quality of Life
Clinical Trials
Guidelines
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Het Gezondheidsraadrapport 'Palliatieve chemotherapie'; risico van begripsverwarring. / Verweij, J.; De Mulder, P. H M; Pinedo, H. M.

In: Nederlands Tijdschrift voor Geneeskunde, Vol. 148, No. 14, 03.04.2004, p. 651-654.

Research output: Contribution to journalArticle

Verweij, J, De Mulder, PHM & Pinedo, HM 2004, 'Het Gezondheidsraadrapport 'Palliatieve chemotherapie'; risico van begripsverwarring', Nederlands Tijdschrift voor Geneeskunde, vol. 148, no. 14, pp. 651-654.
Verweij, J. ; De Mulder, P. H M ; Pinedo, H. M. / Het Gezondheidsraadrapport 'Palliatieve chemotherapie'; risico van begripsverwarring. In: Nederlands Tijdschrift voor Geneeskunde. 2004 ; Vol. 148, No. 14. pp. 651-654.
@article{5c56b02d24954add8053845edae7cf5a,
title = "Het Gezondheidsraadrapport 'Palliatieve chemotherapie'; risico van begripsverwarring",
abstract = "The Dutch Health Council has issued a report advising the government on the care of cancer patients and on palliative chemotherapy in particular. The term palliative chemotherapy is ambiguous and may lead to confusion because it does not mean intention of cure and because the Council makes the assumption that palliative chemotherapy is used to enhance the quality of life, which is not in fact the case. In daily oncological clinical practice, prolonging life is the main objective. The report should have focused on better objectives for the systemic treatment of cancer. Four recommendations are contained within the report: (a) participation in clinical trials should be encouraged; the current implementation of good clinical practice guidelines and the Medical Research (Human Subjects) Act do not provide much support for this recommendation; (b) medication for palliative chemotherapy should be assessed for cost effectiveness; this is a political assessment and the responsibility for its implementation should not lie with the medical profession; (c) the quality of palliative chemotherapy should be ensured, therefore its application should be restricted to the trained medical oncologists; (d) in view of the complexity of the treatment nationwide guidelines are needed.",
author = "J. Verweij and {De Mulder}, {P. H M} and Pinedo, {H. M.}",
year = "2004",
month = "4",
day = "3",
language = "Dutch",
volume = "148",
pages = "651--654",
journal = "Nederlands Tijdschrift voor Geneeskunde",
issn = "0028-2162",
publisher = "Bohn Stafleu van Loghum",
number = "14",

}

TY - JOUR

T1 - Het Gezondheidsraadrapport 'Palliatieve chemotherapie'; risico van begripsverwarring

AU - Verweij, J.

AU - De Mulder, P. H M

AU - Pinedo, H. M.

PY - 2004/4/3

Y1 - 2004/4/3

N2 - The Dutch Health Council has issued a report advising the government on the care of cancer patients and on palliative chemotherapy in particular. The term palliative chemotherapy is ambiguous and may lead to confusion because it does not mean intention of cure and because the Council makes the assumption that palliative chemotherapy is used to enhance the quality of life, which is not in fact the case. In daily oncological clinical practice, prolonging life is the main objective. The report should have focused on better objectives for the systemic treatment of cancer. Four recommendations are contained within the report: (a) participation in clinical trials should be encouraged; the current implementation of good clinical practice guidelines and the Medical Research (Human Subjects) Act do not provide much support for this recommendation; (b) medication for palliative chemotherapy should be assessed for cost effectiveness; this is a political assessment and the responsibility for its implementation should not lie with the medical profession; (c) the quality of palliative chemotherapy should be ensured, therefore its application should be restricted to the trained medical oncologists; (d) in view of the complexity of the treatment nationwide guidelines are needed.

AB - The Dutch Health Council has issued a report advising the government on the care of cancer patients and on palliative chemotherapy in particular. The term palliative chemotherapy is ambiguous and may lead to confusion because it does not mean intention of cure and because the Council makes the assumption that palliative chemotherapy is used to enhance the quality of life, which is not in fact the case. In daily oncological clinical practice, prolonging life is the main objective. The report should have focused on better objectives for the systemic treatment of cancer. Four recommendations are contained within the report: (a) participation in clinical trials should be encouraged; the current implementation of good clinical practice guidelines and the Medical Research (Human Subjects) Act do not provide much support for this recommendation; (b) medication for palliative chemotherapy should be assessed for cost effectiveness; this is a political assessment and the responsibility for its implementation should not lie with the medical profession; (c) the quality of palliative chemotherapy should be ensured, therefore its application should be restricted to the trained medical oncologists; (d) in view of the complexity of the treatment nationwide guidelines are needed.

UR - http://www.scopus.com/inward/record.url?scp=1842418614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842418614&partnerID=8YFLogxK

M3 - Article

VL - 148

SP - 651

EP - 654

JO - Nederlands Tijdschrift voor Geneeskunde

JF - Nederlands Tijdschrift voor Geneeskunde

SN - 0028-2162

IS - 14

ER -